MedTrace Logo

Cognitive ADHD Videogame Exploratory Study

NCT01943539 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2017-12-13

Study results available
· View outcomes & findings →

Summary

A study in ADHD and neuro-typical children to assess EVO game play over 29 days.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

DEVICE

Neuro-typical controls and ADHD will receive EVO game play.

EVO mobile video application

Sponsors & Collaborators

  • Akili Interactive Labs, Inc.

    lead INDUSTRY

Principal Investigators

  • Andrew J Cutler, MD · Florida Clinical Research Center, LLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01943539 on ClinicalTrials.gov